868PDBrain metastases response to nivolumab in patients with renal cell carcinoma (RCC): Prospective analysis from the GETUG-AFU 26 (NIVOREN) trial. (23rd October 2018) - Flippot, R; Dalban, C; Laguerre, B; Borchiellini, D; Gravis, G; Negrier, S; Chevreau, C M; Joly, F; Geoffrois, L; Ladoire, S; Mahammedi, H; Tantot, F; et al.